Free shipping on all orders over $ 500

 About 7 results found for searched term "CD73-IN-2" (0.14 seconds)

Cat.No.  Name Target
M21256 CD73-IN-2 Others
CD73-IN-2 is a potent CD73 inhibitor with an IC50 of 0.09 nM.
M9910 CDKI-73 CDK
CDKI73; Asnuciclib; LS-007
Cdki-73 (LS-007) is an orally active and highly effective CDK9 inhibitor with Ki values of 4 nM, 4 nM and 3 nM against CDK9, CDK1 and CDK2, respectively. Cdki-73 down-regulates phosphorylation of RNA polymerase II. Cdki-73 is also an inhibitor of Rab11.
M10869 OP-5244 Others
OP-5244 is a potent and orally active CD73 inhibitor,IC50 The value is 0.25 nM. OP-5244 reverses the immunosuppressive effect by blocking the production of adenosine, with the potential to conduct cancer research.
M11275 PSB-12379 Others
Psb-12379 is a nucleotide analogue and a potent ECTO-5 '-nucleotidase (CD73) inhibitor with Kis values of 9.03 nM (rat) and 2.21 nM (human).
M29608 MRS4620  Immunology/Inflammation
MRS4620 is a potent CD73 inhibitor, with a Ki of 0.436 nM. MRS4620 can be use for the research of cancer immunoresearch.
M41259 CDD-1733 Anti-infection
CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM.
M43397 Leniolisib phosphate PI3K
Leniolisib (CDZ173) phosphate is a first-in-class, potent and selective PI3Kδ inhibitor with an IC50 value of 11 nM.Leniolisib is more selective for PI3K-δ than PI3K-α (28-fold), PI3K-β (43-fold) and PI3K-γ (257-fold). -γ (257-fold). In a cellular assay, Leniolisib decreased pAKT pathway activity and inhibited the proliferation and activation of B and T cell subsets.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.